- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03961789
Assessment of the Satisfaction of Patient Undergoing Opioid Replacement Therapy Toward Their Management in Community Pharmacy (SATISFY)
Assessment of the Satisfaction of Patient Undergoing Opioid Replacement Therapy Toward Their Management in Community Pharmacy - SATISFY: a Cross-sectional Study
The patient's compliance to his medication therapy, and therefore the success of the treatment, is particularly related to his pharmacy management. Thus, the satisfaction of an individual in their interview with the pharmacist is a very important element.
The pharmacist in his professional activity may have to manage patients with opioid related disorders. Pharmacist activity will result in the dispensing of opioid replacement therapy (ORT), single-use syringes, harm reduction kits and prevention advices for the reduction of toxicity and infection risks.
Since the 1990s, the consumption of ORT has been steadily increasing. According to the OFDT (French Observatory of Drugs and Drug Addiction), the number of patients undergoing ORT is about 150 000 patients. Since high-dose buprenorphine is prescribed for approximately two-thirds of patients, it remains the most frequently prescribed ORT in France.
Recently, a French association assisting drug users (ASUD - Auto-support des usagers de drogues) performed a study in Paris (20/07/2018 - 25/08/2018) to assess the delivery of opioid replacement therapies by community pharmacists. In this study, 71% of pharmacists refused to deliver opioid replacement therapies. The main reasons reported were security (56%) and activity saturation, meaning that pharmacists considered that they had too many patients using opioid drugs. In France, the refusal of a pharmacist to deliver drugs is a punishable offence. According to the Code of ethics of pharmacists, pharmacists must respect life and people without discrimination. Pharmacists have a low perception of patients suffering from opioid addiction. Another study performed by ASUD in 93 community pharmacies, showed that pharmacists used the term "toxicomaniacs" instead of "drug users". Most pharmacists had had a bad experience with drugs users, with physical and verbal aggressions. The conclusions of this study showed that pharmacists lacked knowledge of drug users and drug use. Pharmacists knew about harm reduction kits for opioid users (containing sterile syringes, needles, water, antiseptics, etc.) and had already opened them, but very few knew how to use them. More worryingly, some pharmacists did not understand the harm reduction strategies available It thus appears that community pharmacists have a difficult relationship with patient suffering of opioid related disorders, which can have an impact on patient's satisfaction.
The objective of this study will be to assess the satisfaction of patients undergoing ORT regarding their management by community pharmacists.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Clermont-Ferrand, Frankrike, 63000
- CHU de Clermont-Ferrand
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Patient undergoing opioid replacement therapy
Exclusion Criteria:
- Age <18 years
- Patient unable to understand or write in French
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
---|---|
cohorte 1
patients undergoing opioid replacement therapy
|
patients undergoing opioid replacement therapy
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Score of satisfaction
Tidsram: day 1
|
visual analogic scale (VAS) "Are you satisfied with your management by community pharmacists?"
0: not satisfied - 100: totally satisfied
|
day 1
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Prevention tips given by the pharmacist: risk of infection, overdose, way of using drugs, adverse effects and drug interactions
Tidsram: day 1
|
yes/no
|
day 1
|
Services rendered by the pharmacist: sale of sterile equipment, management of soiled waste, dispensing of opioid replacement therapy
Tidsram: day 1
|
yes/no
|
day 1
|
Perception of the profile / behaviour of pharmacists: welcoming and open to discussion
Tidsram: day 1
|
VAS, 0: not at all - 100 : totally
|
day 1
|
Perception of the profile / behaviour of pharmacists: respect for confidentiality
Tidsram: day 1
|
VAS, 0: not at all - 100 : totally
|
day 1
|
Perception of the profile / behaviour of pharmacists: competent
Tidsram: day 1
|
VAS, 0: not at all - 100 : totally
|
day 1
|
opioid replacement therapy
Tidsram: day 1
|
name, dose, route
|
day 1
|
Number of physician consulted for the last 6 months
Tidsram: day 1
|
number
|
day 1
|
Number of community pharmacy consulted for the last 6 months
Tidsram: day 1
|
number
|
day 1
|
duration of opioid use disorder
Tidsram: day 1
|
number of years/months
|
day 1
|
Demographic information
Tidsram: day 1
|
: age, sex, study level, marital status, health care insurance, monthly income, type of housing
|
day 1
|
Samarbetspartners och utredare
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Mentala störningar
- Kemiskt inducerade störningar
- Substansrelaterade störningar
- Narkotikarelaterade störningar
- Opioidrelaterade störningar
- Läkemedels fysiologiska effekter
- Depressiva medel i centrala nervsystemet
- Agenter från det perifera nervsystemet
- Analgetika
- Sensoriska systemagenter
- Narkotika
- Analgetika, Opioid
Andra studie-ID-nummer
- CHU-434
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Opioidrelaterade störningar
-
University of Southern DenmarkVejle Hospital; Vejle KommuneAvslutadHRQOL (Health Related Quality Of Life)Danmark
-
University of Southern DenmarkNaestved HospitalAvslutadHRQOL (Health Related Quality of Quality)Danmark
-
matthieu clanetAvslutad
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesAvslutadAnalgetika OpioidFörenta staterna
-
Second Hospital of Shanxi Medical UniversityRekryteringOpioid smärtstillande biverkningKina
-
Massachusetts General HospitalAvslutadGraviditet | Kejsarsnitt | Analgetika, Opioid | ReceptFörenta staterna
-
Jagiellonian UniversityRekryteringAnestesi, general | Analgetika, Opioid | Anestesi, EndotrakealPolen
-
Jagiellonian UniversityRekryteringAnalgetika, Opioid | Anestesi; Skadlig effektPolen
-
University of MalayaAvslutadTrauma | Opioid smärtstillande biverkningMalaysia
-
Qianfoshan HospitalHar inte rekryterat ännuAnalgetika, opioid | Bariatrisk kirurgiKina
Kliniska prövningar på patients undergoing opioid replacement therapy
-
Dialco Medical Inc.Indragen
-
University of ParmaOkändAkut njursvikt | Hypofosfatemi | Dialysrelaterad komplikation | HypomagnesemiItalien
-
The Royal Bournemouth HospitalRoyal Bournemouth and Christchurch Hospitals NHS Foundation TrustAvslutadSmärtkontroll | Artroplastik, knäplastikStorbritannien
-
University of Massachusetts, WorcesterHarvard Medical School (HMS and HSDM); National Institute of Mental Health... och andra samarbetspartnersRekryteringPsykisk sjukdom | OpioidanvändningsstörningFörenta staterna
-
Taipei Veterans General Hospital, TaiwanHar inte rekryterat ännuAnestesi | Farmakologisk interaktion | Anestesi; FunktionellTaiwan
-
Uppsala UniversityThe Kamprad Family Foundation for Entrepreneurship, Research & CharityHar inte rekryterat ännuOpioidanvändningsstörning | Alkoholmissbruk | Opioidanvändning | Smärta, kronisk
-
University of IowaHar inte rekryterat ännuDelirium | Spinal Fusion | Smärta, rygg | Thoracolumbar Interfascial Plane BlockFörenta staterna